Skip to Main Content

Paper Details

All-Cause Mortality Risk with Direct Oral Anticoagulants and Warfarin in the Primary Treatment of Venous Thromboembolism.
Thromb Haemost
12
2018
VTE, Venous Thromboembolism, Warfarin, apixaban, dabigatran, edoxaban, patient, patients, renal disease, rivaroxaban, venous thromboembolism, warfarin
Author NameAffiliation
Alvaro AlonsoRollins School of Public Health, Emory University
Alvaro AlonsoRollins School of Public Health, Emory University
Terrence J AdamUniversity of Minnesota
Terrence J AdamInstitute for Health Informatics, University of Minnesota
  • 1 - 4

Datasets

Release 1.2